updated 2/14/2007 1:49:34 PM ET 2007-02-14T18:49:34

Merck & Co. Inc. agreed Wednesday to pay $2.3 billion to resolve several tax disputes, the Internal Revenue Service said.

The drug company's payment includes taxes, interest and penalties stemming from the disputes, which cover the tax years 1993-2001, the IRS said. The IRS said the disputes arose in part from Merck's use of minority equity interest financing transactions.

"This settlement resolves all of the issues that were in dispute," the Whitehouse Station, N.J. company said in a statement.

The company said the settlement is not expected to have an effect on its 2007 earnings because it previously reserved funds to cover the payment.

Merck disclosed in November that it faced liabilities from tax disputes in both the U.S. and Canada. It cited a total of $5.58 billion in potential liabilities at the time.

Merck said the IRS settlement was in the company's best interests given the uncertainty and cost of potential litigation.

Another drug company, GlaxoSmithKline PLC, agreed in September to pay the IRS $3.4 billion in what was the largest tax settlement ever.

Copyright 2007 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com